CME Group Inc (NASDAQ:CME) – Analysts at Oppenheimer increased their Q1 2020 earnings estimates for shares of CME Group in a research note issued to investors on Tuesday, January 14th. Oppenheimer analyst O. Lau now forecasts that the financial services provider will post earnings of $1.75 per share for the quarter, up from their prior estimate of $1.73. Oppenheimer also issued estimates for CME Group’s Q2 2020 earnings at $1.91 EPS and Q3 2020 earnings at $1.95 EPS.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.90 EPS for the quarter, beating the consensus estimate of $1.75 by $0.15. The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The business’s revenue for the quarter was up 41.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.45 EPS.
Several other analysts also recently commented on the stock. Credit Suisse Group started coverage on shares of CME Group in a report on Monday, December 16th. They issued a “neutral” rating on the stock. Deutsche Bank upped their price objective on shares of CME Group from $245.00 to $252.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Sanford C. Bernstein downgraded shares of CME Group from an “outperform” rating to a “market perform” rating in a report on Friday, January 10th. JPMorgan Chase & Co. dropped their price objective on shares of CME Group from $183.00 to $173.00 and set an “underweight” rating on the stock in a report on Friday, December 6th. Finally, ValuEngine downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $208.36.
CME stock opened at $206.86 on Friday. The firm’s fifty day simple moving average is $204.01 and its 200-day simple moving average is $207.02. The company has a market capitalization of $74.23 billion, a P/E ratio of 36.36, a price-to-earnings-growth ratio of 3.52 and a beta of 0.18. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.04 and a quick ratio of 1.04. CME Group has a 12 month low of $161.05 and a 12 month high of $224.91.
A number of large investors have recently bought and sold shares of CME. Nuveen Asset Management LLC raised its position in CME Group by 18,355.3% during the second quarter. Nuveen Asset Management LLC now owns 3,238,530 shares of the financial services provider’s stock worth $628,631,000 after acquiring an additional 3,220,982 shares during the period. Amundi Pioneer Asset Management Inc. raised its position in CME Group by 30.4% during the second quarter. Amundi Pioneer Asset Management Inc. now owns 1,664,500 shares of the financial services provider’s stock worth $323,097,000 after acquiring an additional 388,008 shares during the period. Invesco Ltd. raised its position in CME Group by 20.0% during the second quarter. Invesco Ltd. now owns 1,310,510 shares of the financial services provider’s stock worth $254,384,000 after acquiring an additional 218,421 shares during the period. California Public Employees Retirement System raised its position in CME Group by 11.5% during the third quarter. California Public Employees Retirement System now owns 1,940,906 shares of the financial services provider’s stock worth $410,191,000 after acquiring an additional 200,245 shares during the period. Finally, First Manhattan Co. raised its position in CME Group by 707.4% during the second quarter. First Manhattan Co. now owns 133,078 shares of the financial services provider’s stock worth $25,831,000 after acquiring an additional 116,595 shares during the period. Institutional investors own 84.14% of the company’s stock.
In related news, Director Martin J. Gepsman sold 1,000 shares of the stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $201.16, for a total transaction of $201,160.00. Following the sale, the director now directly owns 34,905 shares of the company’s stock, valued at $7,021,489.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Terrence A. Duffy sold 39,309 shares of the stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $202.38, for a total transaction of $7,955,355.42. Following the sale, the chief executive officer now directly owns 46,684 shares in the company, valued at $9,447,907.92. The disclosure for this sale can be found here. Insiders have sold 40,609 shares of company stock worth $8,216,221 over the last three months. 1.20% of the stock is currently owned by insiders.
The company also recently declared a dividend, which was paid on Wednesday, January 15th. Investors of record on Friday, December 27th were issued a dividend of $2.50 per share. The ex-dividend date was Thursday, December 26th. This is an increase from CME Group’s previous dividend of $1.75. CME Group’s dividend payout ratio is 43.99%.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Recommended Story: Penny Stocks, Risk and Reward Factors
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.